Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).

Cancer ·Vol. 31 ·No. 5 ·1973-05-00 ·Pages 1164-9

Young RC, Walker MD, Canellos GP, Schein PS, Chabner BA, DeVita VT

Abstract

暂无摘要

MeSH Terms

Cyclohexanes/administration & dosage,therapeutic use Evaluation Studies as Topic Hematopoietic System/drug effects Humans Leukopenia/chemically induced Neoplasms/drug therapy Nitrosourea Compounds/administration & dosage,adverse effects,therapeutic use Thrombocytopenia/chemically induced

Chemicals

Cyclohexanes Nitrosourea Compounds

Authors & Affiliations

6 authors, click to expand affiliations / ORCID

Young R C

Walker M D

Canellos G P

Schein P S

Chabner B A

DeVita V T

Article Info

Journal

Cancer

Abbr.

Cancer

ISSN

0008-543X

DOI

10.1002/1097-0142(197305)31:5<1164::aid-cncr2820310519>3.0.co;2-4

Published

1973-05-00

Pages

1164-9

Language

English

Region

United States

NLM ID

0374236

Subset

External Links

PubMed source DOI: 10.1002/1097-0142(197305)31:5<1164::aid-cncr2820310519>3.0.co;2-4 View journal details

Analysis Services

Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).

Contact

WeChat Official Account